Operating Expenses 更改
AbbVie USD 9.71B 96M 2025-06
Abbott USD 9.07B 369M 2025-06
ALKERMES USD 297.68M 4.96M 2025-06
Amgen USD 6.52B 337M 2025-06
AstraZeneca USD 10.95B 1.04B 2025-06
Biogen USD 1.79B 326.1M 2025-06
Bristol-Myers Squibb USD 8.5B 265M 2025-06
Drreddys Laboratories INR 64.87B 2.26B 2024-12
Eli Lilly USD 8.54B 1.22B 2025-06
Gilead Sciences USD 4.35B 80M 2025-06
GlaxoSmithKline GBP 5.96B 663M 2025-06
J&J USD 16.8B 8.54B 2025-06
Medtronic USD 7.49B 845M 2025-04
Merck USD 9.44B 217M 2025-06
Novartis USD 9.97B 1.02B 2025-06
Novo Nordisk 42.77B 3.48B 2025-06
Perrigo USD 1B 36.2M 2025-06
Pfizer USD 11.62B 1.58B 2025-06
Prestige Brands USD 177.77M 30.32M 2025-06
Regeneron Pharmaceuticals USD 2.6B 159.1M 2025-06
Roche Holding CHF 11.43B 1.48B 2024-12
Sanofi EUR 9.02B 702M 2025-06
Sanofi EUR 6.77B 3.75B 2024-12
United Therapeutics USD 521.7M 110.1M 2025-06
Zoetis USD 1.44B 35M 2025-06


Bristol-Myers Squibb 营业费用 - 当前值,历史数据,预测,统计,图表和经济日历 - Aug 2025.